Abiopharma

OKYO Pharma to Present at the Bio International Convention

Hoth Therapeutics Notification (HOTH)

SeaStar Medical - AREVA Institute and SeaStar Medical Announce DoD Award of Prestigious Military Grant to AREVA Institute to Evaluate SeaStarMedical’s SCD Therapy to Advance Breakthrough Burn and Sepsis Research

AREVA Institute and SeaStar Medical Announce DoD Award of Prestigious Military Grant to AREVA Institute to Evaluate SeaStar Medical’s SCD Therapy to Advance Breakthrough Burn and Sepsis Research

AREVA Institute and SeaStar Medical Announce DoD Award of Prestigious Military Grant to AREVA Institute to Evaluate SeaStar Medical’s SCD Therapy to Advance Breakthrough Burn and Sepsis Research

Notable Data on Evofems SOLOSEC in Recurrent Bacterial Vaginosis (BV) Released at ACOG Annual Meeting

Ensysce Biosciences Announces Speakers for Major Symposium at PAINWeek 2025

Harmony Biosciences Presents Preclinical Data Demonstrating Significant Wake-Promoting and Cataplexy-Suppressing Effects of BP1.15205 in Narcolepsy at SLEEP 2025

Johnson & Johnson - New data show TREMFYA®(guselkumab) is the only IL-23 inhibitor proven to significantly inhibit progression of joint structural damage in active psoriatic arthritis

Cellectar Biosciences Provides Update on CLOVER-2 Phase 1 Clinical Trial of Iopofosine I 131 in Pediatric Patients with Relapsed/Refractory High-Grade Glioma